Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Front Immunol ; 12: 617508, 2021.
Artículo en Inglés | MEDLINE | ID: mdl-33732242

RESUMEN

Diet has been associated with several metabolic diseases and may impact immunity. Increased consumption of meals with high oxalate content may stimulate urinary calcium oxalate (CaOx) crystals, which are precursors to CaOx kidney stones. We previously reported that CaOx stone formers have decreased monocyte cellular bioenergetics compared to healthy participants and oxalate reduces monocyte metabolism and redox status in vitro. The purpose of this study was to investigate whether dietary oxalate loading impacts monocyte cellular bioenergetics, mitochondrial complex activity, and inflammatory signaling in humans. Healthy participants (n = 40; 31.1 ± 1.3 years) with a BMI of 24.9 ± 0.6 kg/m2 consumed a controlled low oxalate diet for 3 days before drinking a blended preparation of fruits and vegetables containing a large amount of oxalate. Blood and urine were collected before (pre-oxalate) and for 5 h after the oxalate load to assess urinary oxalate levels, monocyte cellular bioenergetics and mitochondrial complex activity, and plasma cytokine/chemokine levels. Urinary oxalate levels significantly increased in post-oxalate samples compared to pre-oxalate samples. Monocyte cellular bioenergetics, mitochondrial complex I activity, and plasma cytokine and chemokine levels were altered to varying degrees within the study cohort. We demonstrate for the first time that dietary oxalate loading may impact monocyte metabolism and immune response in a cohort of healthy adults, but these response are variable. Further studies are warranted to understand oxalate mediated mechanisms on circulating monocytes and how this potentially influences CaOx kidney stone formation. Clinical Trial Registration: ClinicalTrials.gov, identifier NCT03877276.


Asunto(s)
Suplementos Dietéticos , Metabolismo Energético/efectos de los fármacos , Monocitos/efectos de los fármacos , Monocitos/metabolismo , Oxalatos/administración & dosificación , Transducción de Señal/efectos de los fármacos , Adulto , Biomarcadores , Proteínas del Complejo de Cadena de Transporte de Electrón/metabolismo , Femenino , Humanos , Inflamación/etiología , Inflamación/metabolismo , Inflamación/patología , Recuento de Leucocitos , Masculino , Mitocondrias/efectos de los fármacos , Mitocondrias/metabolismo , Urinálisis
2.
Kidney Int Rep ; 5(7): 1040-1051, 2020 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-32647761

RESUMEN

INTRODUCTION: Crystalluria is thought to be associated with kidney stone formation and can occur when urine becomes supersaturated with calcium, oxalate, and phosphate. The principal method used to identify urinary crystals is microscopy, with or without a polarized light source. This method can detect crystals above 1 µm in diameter (microcrystals). However, analyses of calcium oxalate kidney stones have indicated that crystallite components in these calculi are 50-100 nm in diameter. Recent studies have suggested that nanocrystals (<200 nm) elicit more injury to renal cells compared to microcrystals. The purpose of this study was to determine whether (i) urinary nanocrystals can be detected and quantified by nanoparticle tracking analysis (NTA, a high-resolution imaging technology), (ii) early-void urine samples from healthy subjects contain calcium nanocrystals, and (iii) a dietary oxalate load increases urinary nanocrystal formation. METHODS: Healthy subjects consumed a controlled low-oxalate diet for 3 days before a dietary oxalate load. Urinary crystals were isolated by centrifugation and assessed using NTA before and 5 hours after the oxalate load. The morphology and chemical composition of crystals was assessed using electron microscopy, Fourier-transform infrared spectroscopy (FTIR), and ion chromatography-mass spectrometry (IC-MS). RESULTS: Urinary calcium oxalate nanocrystals were detected in pre-load samples and increased substantially following the oxalate load. CONCLUSION: These findings indicate that NTA can quantify urinary nanocrystals and that meals rich in oxalate can promote nanocrystalluria. NTA should provide valuable insight about the role of nanocrystals in kidney stone formation.

3.
Innate Immun ; 24(5): 278-284, 2018 07.
Artículo en Inglés | MEDLINE | ID: mdl-29991305

RESUMEN

Human breast milk has been shown to reduce the incidence of necrotizing enterocolitis (NEC). Breast milk has many components (immunoglobulins, proteins, fat, and, of recent interest, exosomes), but the specific component that affords protection against NEC is not known. Exosomes are small-nanometer vesicles that are rich in protein, lipid, and microRNA. Here, we hypothesized that human breast milk-derived exosomes can protect intestinal epithelial cells (IECs) from cell death. Human breast milk was collected, separated using ultracentrifugation, and quantified using NanoSight tracking analysis. Purified exosomes were added to IECs that had been treated with varying concentrations of H2O2. Cells were then incubated overnight with the human breast milk-derived exosomes and assessed for cell viability. Western blot analysis showed that both clathrin and CD81 were present in the purified sample. Oxidative stress using H2O2 caused a 50% decrease in cell viability and human breast milk-derived exosomes had a protective effect in IECs. In the presence of H2O2, exosomes had a statistically significant protective effect. The protection seen by human breast milk-derived exosomes was not attenuated by cycloheximide. Thus, human breast milk-derived exosomes allow IECs to be protected from oxidative stress, but the mechanism is still not clear. Exosomes derived from human breast milk are an attractive treatment concept for children with intestinal injury.


Asunto(s)
Enterocolitis Necrotizante/inmunología , Exosomas/metabolismo , Mucosa Intestinal/patología , Leche Humana/metabolismo , Muerte Celular , Línea Celular , Supervivencia Celular , Clatrina/metabolismo , Femenino , Humanos , Peróxido de Hidrógeno/metabolismo , Mucosa Intestinal/efectos de los fármacos , Estrés Oxidativo , Tamaño de la Partícula , Tetraspanina 28/metabolismo
4.
Redox Biol ; 15: 207-215, 2018 05.
Artículo en Inglés | MEDLINE | ID: mdl-29272854

RESUMEN

Monocytes/macrophages are thought to be recruited to the renal interstitium during calcium oxalate (CaOx) kidney stone disease for crystal clearance. Mitochondria play an important role in monocyte function during the immune response. We recently determined that monocytes in patients with CaOx kidney stones have decreased mitochondrial function compared to healthy subjects. The objective of this study was to determine whether oxalate, a major constituent found in CaOx kidney stones, alters cell viability, mitochondrial function, and redox homeostasis in THP-1 cells, a human derived monocyte cell line. THP-1 cells were treated with varying concentrations of CaOx crystals (insoluble form) or sodium oxalate (NaOx; soluble form) for 24h. In addition, the effect of calcium phosphate (CaP) and cystine crystals was tested. CaOx crystals decreased cell viability and induced mitochondrial dysfunction and redox imbalance in THP-1 cells compared to control cells. However, NaOx only caused mitochondrial damage and redox imbalance in THP-1 cells. In contrast, both CaP and cystine crystals did not affect THP-1 cells. Separate experiments showed that elevated oxalate also induced mitochondrial dysfunction in primary monocytes from healthy subjects. These findings suggest that oxalate may play an important role in monocyte mitochondrial dysfunction in CaOx kidney stone disease.


Asunto(s)
Riñón/metabolismo , Monocitos/efectos de los fármacos , Nefrolitiasis/metabolismo , Oxidación-Reducción/efectos de los fármacos , Adulto , Fosfatos de Calcio/metabolismo , Línea Celular/efectos de los fármacos , Supervivencia Celular/efectos de los fármacos , Homeostasis/efectos de los fármacos , Humanos , Riñón/patología , Masculino , Mitocondrias/efectos de los fármacos , Mitocondrias/patología , Nefrolitiasis/patología , Oxalatos/química , Oxalatos/farmacología
5.
Exp Cell Res ; 352(2): 202-206, 2017 03 15.
Artículo en Inglés | MEDLINE | ID: mdl-28167131

RESUMEN

Necrotizing enterocolitis is a common but serious complication among premature babies. Currently, there are limited treatment options. These include intensive supportive care and surgical intervention. In this study, we hypothesize that erythropoietin (Epo) could be protective against cell necrosis by increasing the levels of glutathione. This can be regulated by increasing the activity of system xC-. This was demonstrated using intestinal epithelial cells (IEC-6) as a model system. S4-CPG and sulfasalazine pharmacologically inhibit xCT, which induced cell death. Our data showed a dose dependent decrease in cell viability when treated with both inhibitors. In addition, the IEC-6 cells displayed a dose dependent increase when treated with Epo. In conclusion, Epo can be protective against cell death and ultimately be considered as a treatment option for intestinal epithelial cell death.


Asunto(s)
Sistema de Transporte de Aminoácidos y+/metabolismo , Enterocolitis Necrotizante/metabolismo , Eritropoyetina/farmacología , Mucosa Intestinal/metabolismo , Sistema de Transporte de Aminoácidos y+/antagonistas & inhibidores , Sistema de Transporte de Aminoácidos y+/genética , Animales , Línea Celular , Supervivencia Celular/efectos de los fármacos , Enterocolitis Necrotizante/patología , Glutatión/metabolismo , Humanos , Lactante , Mucosa Intestinal/efectos de los fármacos , Mucosa Intestinal/patología , Ratas , Sulfasalazina/farmacología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA